Akèy › Ipètansyon atè pulmonè › Kansas
Etid klinik pou Ipètansyon atè pulmonè nan Kansas
7 etid pou Ipètansyon atè pulmonè ap chèche patisipan nan sit nan Kansas.
Vil nan Kansas
Tèks ofisyèl etid la (Anglè)
A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)
- USA010, Kansas City
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Sep 16, 2026 · NCT07481981An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
- University of Kansas Medical Center, Kansas City
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Sep 2, 2026 · NCT07365332A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- The University of Kansas Medical Center Research Institute, Kansas City
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Aug 10, 2026 · NCT07175038Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
- University of Kansas Medical Center, Kansas City
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Jul 29, 2026 · NCT06274801A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
- U of Kansas Medical Center, Kansas City
Ap rekriteFaz 1/2Volontè an sante akeyi
Laj 18 a 100 · Tout sèks · Mizajou Jul 21, 2026 · NCT06649110Pulmonary Hypertension Association Registry
- KU Medical Center, Kansas City
Ap rekriteEtid obsèvasyon
Laj 0 ak plis · Tout sèks · Mizajou Nov 14, 2025 · NCT04071327Pulmonary Hypertension Biorepository and Registry
- University of Kansas Medical Center, Kansas City
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 1, 2025 · NCT04808596Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.